Screening of Mangrove Endophytic Fungi for Bioactive Compounds
Total Page:16
File Type:pdf, Size:1020Kb

Load more
Recommended publications
-
Oakland Sheriff's Dept Fee Schedule 02.09
CLIENT SERVICE FEE SCHEDULE NAME: OAKLAND SHERIFF'S DEPT ACCT SETUP: 2/1/87 REP ID: GRP BILL #: 22857610 GRP CD: N DISC %: FS ID: 01 FS DESCR: 2003 CLIENT FEES PRICE TYPE: SERVICE CODE SERVICE NAME UPF PRICE TEST PRICE UPF DISC IND 0000018 PLT SODIUM CITRATE $12.86 $4.37 Y 0000022 APC RESISTANCE $101.62 $34.55 Y 0000201 ACETAMINOPHEN $110.24 $37.48 Y 0000202 ACETALDEHYDE (B) $73.00 $73.00 N 0000203 ARSENIC,TISSUE $302.00 $302.00 N 0000204 DHT $182.70 $62.12 Y 0000205 ACETONE (B) $102.20 $34.75 Y 0000206 ACETYLCHOLINE $165.00 $56.10 Y 0000208 ACID PHOS, PROS, IMM $35.60 $12.10 Y 0000210 ACID PHOS, TOTAL $37.22 $12.65 Y 0000211 ACTH $110.00 $37.40 Y 0000212 AMYLASE (U) $45.45 $15.45 Y 0000213 IMMUNOFIX, UR $67.39 $22.91 Y 0000214 ETHOSUXIMIDE $112.07 $38.10 Y 0000216 ANTITHROMBIN III ACT $170.46 $57.96 Y 0000219 ALA, QUANT $107.10 $36.41 Y 0000223 ALBUMIN $22.88 $22.88 N 0000224 ALBUMIN, CSF $36.25 $12.33 Y 0000225 CYCLIC AMP, UR $205.80 $69.97 Y 0000227 ALDOLASE $32.08 $10.91 Y 0000228 A-2-MACROGLOB. $78.75 $26.78 Y 0000229 ALDOSTERONE (U) $251.58 $85.54 Y 0000230 ALDOSTERONE $207.10 $70.41 Y 0000231 ALK PHOS ISOENZYMES $61.34 $20.86 Y 0000232 AFP, FLUID W/RFX $107.40 $36.52 Y 0000233 LEUKOCYTE ALK PHOS $34.60 $11.76 Y 0000234 ALKALINE PHOSPHATASE $22.88 $22.88 N 0000235 A-1-ANTITRYPSN $40.22 $13.67 Y 0000236 AMIKACIN $99.91 $33.97 Y 0000237 AFP,TUMOR (CHIRON) $53.86 $18.31 Y 0000238 AMINO ACID SCR $87.15 $29.63 Y 0000240 RAST PANEL #103 $62.00 $62.00 N 0000241 AMPHETAMINE GC/MS $111.70 $37.98 Y 0000242 CYCLIC AMP $205.80 $69.97 Y 0000243 AMYLASE $16.42 $5.58 Y 0000248 HACKBERRY IGE $35.40 $35.40 N 0000249 ANA W/RFX $55.00 $18.70 Y 0000250 *AMIKACIN,PEAK&TROUGH $199.83 $67.94 Y 0000251 ANDROSTENEDIONE $180.65 $61.42 Y 0000252 ANTI-DIUR. -
ISOLATION, CHARACTERISATION AND/OR EVALUATION of PLANT EXTRACTS for ANTICANCER POTENTIAL KARUPPIAH PILLAI MANOHARAN (M.Sc., M.Ph
ISOLATION, CHARACTERISATION AND/OR EVALUATION OF PLANT EXTRACTS FOR ANTICANCER POTENTIAL KARUPPIAH PILLAI MANOHARAN (M.Sc., M.Phil., B.Ed.,) A THESIS SUBMITTED FOR THE DEGREE OF DOCTOR OF PHILOSOPHY DEPARTMENT OF CHEMISTRY NATIONAL UNIVERSITY OF SINGAPORE 2006 Acknowledgements I wish to express my sincere gratitude and appreciation to my supervisors, Associate Prof. Yang Dai Wen and Associate Prof. Tan, Benny Kwong Huat for their advice, suggestions, constructive criticisms, critical comments and constant guidance throughout the course my study. I am very thankful to Asst. Prof. Henry, Mok Yu-Keung; his supervisor-like role throughout my research work is greatly appreciated. I am very grateful to Prof. Sim Keng Yeow for his help, support and guidance at the beginning of this course of study. I would like to thank all the technical staffs of Departments of Chemistry and Pharmacology for their superb technical assistance. My sincere thanks are due to Ms. Annie Hsu for her technical assistance at the traditional medicine and natural product research laboratory, Department of Pharmacology, Faculty of Medicine. I would like to thank Dr. Fan Sing Jong, NMR Manager for his help in the structure elucidation. I would like to thank Associate Prof. Hugh Tan Tiang Wah and Chua Keng Soon, Senior Laboratory Officer (RMBR), Herbarium, for the identification of plant materials, Eugenia grandis and Fagraea fragrans. I am very grateful to the former head Prof. Lee Hian Kee and the present head Prof. Hor Tzi Sum, Andy, Department of Chemistry for facilitating requests and approvals during the period of my study. My appreciation also goes to all my friends. -
Endophytic Fungi: Treasure for Anti-Cancerous Compounds
International Journal of Pharmacy and Pharmaceutical Sciences ISSN- 0975-1491 Vol 8, Issue 8, 2016 Review Article ENDOPHYTIC FUNGI: TREASURE FOR ANTI-CANCEROUS COMPOUNDS ANAND DILIP FIRODIYAa*, RAJESH KUMAR TENGURIAb aCSRD, Peoples University, Bhopal 462037, Madhya Pradesh, India, bDepartment of Botany, Govt. PG College, Rajgarh 496551, Madhya Pradesh, India Email: [email protected] Received: 22 Apr 2016 Revised and Accepted: 20 June 2016 ABSTRACT Endophytic fungi that live asymptomatically inside the plant tissues have novel bioactive metabolites exhibiting a variety of biological activities, especially against cancer. This review highlights the research progress on the production of anticancer compounds by endophytic fungi from 1990- 2015. Anticancer activity is generally associated with the cytotoxicity of the compounds present in the endophytic fungi. The ubiquitous nature of endophytic fungi synthesise diverse chemicals with promising anticancer activity from either their original host or related species. Modification in fermentation parameters and genetic insight of endophytes may produce novel anti-cancerous compounds. Keywords: Cancer, Medicinal plants, Secondary metabolites © 2016 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/) INTRODUCTION endophytic fungi detectable by high-performance liquid chromate- graphy, nuclear magnetic resonance, mass spectrophotometer and The interest in the biogenic medicines has revived throughout the X-ray crystallography and its cytotoxicity of the bioactive world, as the increase in awareness of the health hazards and compounds against cancer cell lines. The compounds with potential toxicity associated with the random use of synthetic drugs and application were also considered in the selection of antitumor antibiotics [1]. -
Discogenic Back Pain : the Induction and Prevention of a Pro-Inflammatory Cascade in Intervertebral Disc Cells in Vitro
Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2013 Discogenic back pain : the induction and prevention of a pro-inflammatory cascade in intervertebral disc cells in vitro Quero, Lilian Abstract: Low back pain (LBP) is a prevalent symptom that more than 80% of the population experience once in their lifetime. This can lead to severe impairment of the workaday life and cause enormous costs in the society. Because LBP mostly appears as a non-specific back pain symptom, provoked by the spine or its environment, the evaluation of the source is bearing some challenge. Whereas the pathomorphological source of pain is well defined in the specific spinal pathology, such as in the caseofa scoliosis or sciatica, finding a correlation between the source of pain and a certain abnormality isdifficult in non-specific LPB symptoms. This is accompanied by the disadvantage of finding a suitable treatment. One possible source of LPB represents the intervertebral disc (IVD), which can alter from a pain free (asymptomatic) to a painful (symptomatic) IVD during degeneration, leading to so called discogenic back pain. Provocative discography is to date the only means to assign LBP to a degenerated disc, with its usage being under dispute. The IVD has an important function as a shock absorber, as there is a high load on the spine. During a lifetime, our IVD becomes degenerated which means its matrix is more catabolized then anabolized, leading to an overall matrix breakdown and decreased quality of the IVD. The matrix consists of long protein chains and sugars, responsible for the ability to attract water, comparable to a sponge. -
And Mushroom-Associated Alkaloids from Two Behavior Modifying
bioRxiv preprint doi: https://doi.org/10.1101/375105; this version posted December 18, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Psychoactive plant- and mushroom-associated alkaloids from two behavior modifying 2 cicada pathogens 3 4 Greg R. Boyce1, Emile Gluck-Thaler2, Jason C. Slot2, Jason E. Stajich3, William J. Davis4, Tim 5 Y. James4, John R. Cooley5, Daniel G. Panaccione1, Jørgen Eilenberg6, Henrik H. De Fine Licht6, 6 Angie M. Macias1, Matthew C. Berger1, Kristen L. Wickert1, Cameron M. Stauder1, Ellie J. 7 Spahr1, Matthew D. Maust1, Amy M. Metheny1, Chris Simon5, Gene Kritsky7, Kathie T. Hodge8, 8 Richard A. Humber8,9, Terry Gullion10, Dylan P. G. Short11, Teiya Kijimoto1, Dan Mozgai12, 9 Nidia Arguedas13, Matt T. Kasson1,* 10 11 1Division of Plant and Soil Sciences, West Virginia University, Morgantown, West Virginia, 12 26506, USA. 13 2Department of Plant Pathology, The Ohio State University, Columbus, Ohio 43210, USA. 14 3Department of Microbiology and Plant Pathology and Institute for Integrative Genome Biology, 15 University of California, Riverside, California 92521, USA. 16 4Department of Ecology and Evolution, University of Michigan, Ann Arbor, Michigan 48109, 17 USA. 18 5Department of Ecology and Evolutionary Biology, University of Connecticut, Storrs, 19 Connecticut 06269, USA. 20 6Department of Plant and Environmental Science, University of Copenhagen, Denmark. 21 7Department of Biology, Mount St. Joseph University, Cincinnati, Ohio 45233, USA. 22 8Plant Pathology & Plant-Microbe Biology, School of Integrative Plant Science, Cornell 23 University, Ithaca, New York 14853, USA. -
Fungal Endophytes As Efficient Sources of Plant-Derived Bioactive
microorganisms Review Fungal Endophytes as Efficient Sources of Plant-Derived Bioactive Compounds and Their Prospective Applications in Natural Product Drug Discovery: Insights, Avenues, and Challenges Archana Singh 1,2, Dheeraj K. Singh 3,* , Ravindra N. Kharwar 2,* , James F. White 4,* and Surendra K. Gond 1,* 1 Department of Botany, MMV, Banaras Hindu University, Varanasi 221005, India; [email protected] 2 Department of Botany, Institute of Science, Banaras Hindu University, Varanasi 221005, India 3 Department of Botany, Harish Chandra Post Graduate College, Varanasi 221001, India 4 Department of Plant Biology, Rutgers University, New Brunswick, NJ 08901, USA * Correspondence: [email protected] (D.K.S.); [email protected] (R.N.K.); [email protected] (J.F.W.); [email protected] (S.K.G.) Abstract: Fungal endophytes are well-established sources of biologically active natural compounds with many producing pharmacologically valuable specific plant-derived products. This review details typical plant-derived medicinal compounds of several classes, including alkaloids, coumarins, flavonoids, glycosides, lignans, phenylpropanoids, quinones, saponins, terpenoids, and xanthones that are produced by endophytic fungi. This review covers the studies carried out since the first report of taxol biosynthesis by endophytic Taxomyces andreanae in 1993 up to mid-2020. The article also highlights the prospects of endophyte-dependent biosynthesis of such plant-derived pharma- cologically active compounds and the bottlenecks in the commercialization of this novel approach Citation: Singh, A.; Singh, D.K.; Kharwar, R.N.; White, J.F.; Gond, S.K. in the area of drug discovery. After recent updates in the field of ‘omics’ and ‘one strain many Fungal Endophytes as Efficient compounds’ (OSMAC) approach, fungal endophytes have emerged as strong unconventional source Sources of Plant-Derived Bioactive of such prized products. -
High-Throughput Screen of Natural Product Libraries for Hsp90 Inhibitors
Biology 2014, 3, 101-138; doi:10.3390/biology3010101 OPEN ACCESS biology ISSN 2079-7737 www.mdpi.com/journal/biology Article High-Throughput Screen of Natural Product Libraries for Hsp90 Inhibitors 1,† Jason Davenport 1, Maurie Balch 1, Lakshmi Galam , Antwan Girgis 2, Jessica Hall 2, Brian S. J. Blagg 2 and Robert L. Matts 1,* 1 Department of Biochemistry and Molecular Biology, 246 Noble Research Center, Oklahoma State University, Stillwater, OK 74078, USA; E-Mails: [email protected] (J.D.); [email protected] (M.B.); [email protected] (L.G.) 2 Department of Medicinal Chemistry, The University of Kansas, 1251 Wescoe Hall Drive, Malott 4070, Lawrence, KS 66045, USA; E-Mails: [email protected] (A.G.); [email protected] (J.H.); [email protected] (B.S.J.B.) † Current address: Department of Internal Medicine, University of South Florida School of Medicine, 12901 Bruce B. Downs Blvd. MDC 19, Tampa, FL 33612, USA. * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +1-405-744-6200; Fax: +1-405-744-7799. Received: 7 January 2014; in revised form: 22 January 2014 / Accepted: 22 January 2014 / Published: 10 February 2014 Abstract: Hsp90 has become the target of intensive investigation, as inhibition of its function has the ability to simultaneously incapacitate proteins that function in pathways that represent the six hallmarks of cancer. While a number of Hsp90 inhibitors have made it into clinical trials, a number of short-comings have been noted, such that the search continues for novel Hsp90 inhibitors with superior pharmacological properties. -
Fungal Endophytes: Promising Tools for Pharmaceutical Science
Int. J. Pharm. Sci. Rev. Res., 25(2), Mar – Apr 2014; Article No. 25, Pages: 128-138 ISSN 0976 – 044X Research Article Fungal Endophytes: Promising Tools for Pharmaceutical Science Pramod Kumar Pandey1,2, Siddhartha Singh1, Raj Naraian Singh Yadav2, Amit Kumar Singh1*, M. Chandra Kumar Singh1 1Department of Basic Science and Humanities, College of Horticulture and Forestry, Central Agricultural University, Pasighat, Arunachal Pradesh, India. 2Centre for Studies in Biotechnology, Dibrugarh University, Dibrugarh, Assam, India. *Corresponding author’s E-mail: [email protected] Accepted on: 27-01-2014; Finalized on: 31-03-2014. ABSTRACT Fungal endophytes are microorganisms that internally infect living plant tissues without causing any visible symptom of infection, and live in mutualistic relationship with plants for at least a part of their life cycle. Every plant in the world is reservoir of one or more number of endophytes. In recent year’s special attention have been made towards endophytic fungi because of their ability to synthesize several novel bioactive compounds not previously known to biological system which are important for pharmaceutical, agricultural and industrial sector. This review describes information on endophyte diversity, as well as production of secondary metabolites with special emphasis on anti cancerous, antimicrobial, antiviral, antibiotics along with huge number of other secondary metabolites for commercial exploitation in pharmaceutical and medical field. Furthermore, the chemical potential of endophytic fungi for drug discovery will be discussed with focus on the detection of pharmaceutically valuable plant constituents as products of fungal biosynthesis in recent years. At present a huge world population is suffering from the problem caused by drug resistant microbes (bacteria, parasitic protozoans and fungus) which decreases the efficiency of synthetic drugs. -
COMPARATIVE BIOLOGICAL EVALUATION of SIX ENDOPHYTIC FUNGI ISOLATED from VINCA ROSEA LEAVES Ahmed M
Az. J. Pharm Sci. Vol. 59, March, 2019. 137 COMPARATIVE BIOLOGICAL EVALUATION OF SIX ENDOPHYTIC FUNGI ISOLATED FROM VINCA ROSEA LEAVES Ahmed M. Metwaly*1, Mohamed A. Ashour1, Shabana Khan2, Guoyi Ma2, Hazem A. Kadry1, Atef A. El-Hela1, Abd-Elsalam I. Mohammad1, Stephen J. Cutler3 and Samir A. Ross2 1Department of Pharmacognosy, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt 2 Department of Biomolecular Science, National Center for Natural Products Research, University of Mississippi, Oxford, MS 38677, USA 3Department of Medicinal Chemistry, School of Pharmacy, the University of Mississippi, Oxford, MS 38677, USA *Corresponding authors: [email protected] Abstract In this study, a total of six endophytic fungi have been isolated from Vinca rosea (Apocynaceae) leaves growing in Egypt. The isolated fungi were identified morphologically and microscopically up to species to be; Alternaria phragmospora, Aspergillus awamori, Penicillium duclauxii, Penicillium melinii, Nigrospora sphaerica and Mucor ramosissimus. The extracts of the all identified fungi were screened biologically for antileukemic, cytotoxic, antimalarial, antileishmanial, antimicrobial, antioxidant and anti-inflammatory activities as well as for cannabinoid and opioid receptor binding affinities. Out of the six examined fungal extracts four exhibited promising antimalarial activities, four showed modeate antileukemic activities and two of them exhibited cytotoxic activities, three showed antioxidant activities, three exhibited anti-inflammatory activities, and the only one showed an antifungal activity. Alternaria phragmospora was the most active antimalarial agent inhibiting Plasmodium falciparum D6 and W2 clones with IC50 values of 1.9 and 2.1 μg/mL, respectively. Alternaria phragmospora extract was subjected to liquid-liquid partition using 90% MeOH, hexane then BuOH and H2O. -
Isolation and Characterization of Fungal Endophytes Isolated from Medicinal Plant Ephedra Pachyclada As Plant Growth-Promoting
biomolecules Article Isolation and Characterization of Fungal Endophytes Isolated from Medicinal Plant Ephedra pachyclada as Plant Growth-Promoting Ahmed Mohamed Aly Khalil 1,2, Saad El-Din Hassan 1,* , Sultan M. Alsharif 3, Ahmed M. Eid 1 , Emad El-Din Ewais 1, Ehab Azab 4,5 , Adil A. Gobouri 6, Amr Elkelish 7 and Amr Fouda 1,* 1 Department of Botany and Microbiology, Faculty of Science, Al-Azhar University, Nasr City, Cairo 11884, Egypt; [email protected] (A.M.A.K.); [email protected] (A.M.E.); [email protected] (E.E.-D.E.) 2 Biology Department, College of Science, Taibah University, Yanbu 41911, Saudi Arabia 3 Biology Department, Faculty of Science, Taibah University, Al Madinah P.O. Box 887, Saudi Arabia; [email protected] 4 Department of Biotechnology, College of Science, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia; [email protected] 5 Botany and Microbiology Department, Faculty of Science, Zagazig University, Zagazig 44519, Sharkia, Egypt 6 Department of Chemistry, College of Science, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia; [email protected] 7 Botany Department, Faculty of Science, Suez Canal University, Ismailia 41522, Egypt; [email protected] * Correspondence: [email protected] (S.E.-D.H.); [email protected] (A.F.); Citation: Khalil, A.M.A.; Tel.: +20-102-3884804 (S.E.-D.H.); +20-111-3351244 (A.F.) Hassan, S.E.-D.; Alsharif, S.M.; Eid, A.M.; Ewais, E.E.-D.; Azab, E.; Abstract: Endophytic fungi are widely present in internal plant tissues and provide different ben- Gobouri, A.A.; Elkelish, A.; Fouda, A. -
RSC COFI Prelims 1..4
The Chemistry of Fungi James R. Hanson Department of Chemistry, University of Sussex, Brighton, UK ISBN: 978-0-85404-136-7 A catalogue record for this book is available from the British Library r James R. Hanson, 2008 All rights reserved Apart from fair dealing for the purposes of research for non-commercial purposes or for private study, criticism or review, as permitted under the Copyright, Designs and Patents Act 1988 and the Copyright and Related Rights Regulations 2003, this publication may not be reproduced, stored or transmitted, in any form or by any means, without the prior permission in writing of The Royal Society of Chemistry or the copyright owner, or in the case of reproduction in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK, or in accordance with the terms of the licences issued by the appropriate Reproduction Rights Organization outside the UK. Enquiries concerning reproduction outside the terms stated here should be sent to The Royal Society of Chemistry at the address printed on this page. Published by The Royal Society of Chemistry, Thomas Graham House, Science Park, Milton Road, Cambridge CB4 0WF, UK Registered Charity Number 207890 For further information see our web site at www.rsc.org Preface The diverse structures, biosyntheses and biological activities of fungal meta- bolites have attracted chemists for many years. This book is an introduction to the chemistry of fungal metabolites. The aim is to illustrate, within the context of fungal metabolites, the historical progression from chemical to spectroscopic methods of structure elucidation, the development in biosynthetic studies from establishing sequences and mechanisms to chemical enzymology and genetics and the increasing understanding of the biological roles of natural products. -
WHO Monographs on Selected Medicinal Plants. Volume 3
WHO monographs on WHO monographs WHO monographs on WHO published Volume 1 of the WHO monographs on selected medicinal plants, containing 28 monographs, in 1999, and Volume 2 including 30 monographs in 2002. This third volume contains selected an additional collection of 32 monographs describing the quality control and use of selected medicinal plants. medicinal Each monograph contains two parts, the first of which provides plants selected medicinal plants pharmacopoeial summaries for quality assurance purposes, including botanical features, identity tests, purity requirements, Volume 3 chemical assays and major chemical constituents. The second part, drawing on an extensive review of scientific research, describes the clinical applications of the plant material, with detailed pharmacological information and sections on contraindications, warnings, precautions, adverse reactions and dosage. Also included are two cumulative indexes to the three volumes. The WHO monographs on selected medicinal plants aim to provide scientific information on the safety, efficacy, and quality control of widely used medicinal plants; provide models to assist Member States in developing their own monographs or formularies for these and other herbal medicines; and facilitate information exchange among Member States. WHO monographs, however, are Volume 3 Volume not pharmacopoeial monographs, rather they are comprehensive scientific references for drug regulatory authorities, physicians, traditional health practitioners, pharmacists, manufacturers, research scientists